We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.24%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$463B
AUM Growth
+$17.5B
Cap. Flow
-$1.61B
Cap. Flow %
-0.35%
Top 10 Hldgs %
12.49%
Holding
2,596
New
97
Increased
1,091
Reduced
793
Closed
67

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$1.3B
2
AAL icon
American Airlines Group
AAL
+$853M
3
ISRG icon
Intuitive Surgical
ISRG
+$816M
4
MS icon
Morgan Stanley
MS
+$681M
5
WYNN icon
Wynn Resorts
WYNN
+$622M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$1.4B
2
EBAY icon
eBay
EBAY
+$763M
3
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$760M
4
AVGO icon
Broadcom
AVGO
+$757M
5
USB icon
US Bancorp
USB
+$686M

Sector Composition

Rank Sector Weight
1 Healthcare 16.64%
2 Consumer Discretionary 13.46%
3 Financials 12.79%
4 Industrials 12.13%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLDX icon
1851
Celldex Therapeutics
CLDX
$3.35B
$618K ﹤0.01%
2,523
+300
+13% +$67.7K
TIVO
1852
DELISTED
TIVO INC
TIVO
$616K ﹤0.01%
47,700
+11,100
+30% +$135K
CSG
1853
DELISTED
CHAMBERS STR PPTYS COM
CSG
$615K ﹤0.01%
76,500
+14,000
+22% +$110K
CVSA
1854
Covista Inc
CVSA
$4.49B
$614K ﹤0.01%
14,500
– –
SBGI icon
1855
Sinclair Inc
SBGI
$1.03B
$612K ﹤0.01%
17,610
– –
LAD icon
1856
Lithia Motors
LAD
$8.32B
$611K ﹤0.01%
6,500
– –
IDTI
1857
DELISTED
Integrated Device Technology I
IDTI
$611K ﹤0.01%
39,500
– –
CHMT
1858
DELISTED
Chemtura Corporation
CHMT
$611K ﹤0.01%
23,400
– –
MENT
1859
DELISTED
Mentor Graphics Corp
MENT
$610K ﹤0.01%
28,280
– –
MZTI
1860
The Marzetti Company
MZTI
$3.22B
$609K ﹤0.01%
6,400
– –
RYL
1861
DELISTED
RYLAND GROUP INC
RYL
$609K ﹤0.01%
15,446
+2,800
+22% +$108K
PNK
1862
DELISTED
Pinnacle Entertainment Inc.
PNK
$607K ﹤0.01%
24,100
– –
CDP icon
1863
COPT Defense Properties
CDP
$4.23B
$603K ﹤0.01%
21,700
– –
NWN icon
1864
Northwest Natural Holdings
NWN
$2.14B
$603K ﹤0.01%
12,790
-1,200
-9% -$53.8K
MPT
1865
Medical Properties Trust
MPT
$2.51B
$596K ﹤0.01%
45,000
– –
MNR
1866
DELISTED
Monmouth Real Estate Investment Corp
MNR
$592K ﹤0.01%
58,982
– –
ALE
1867
DELISTED
Allete
ALE
$591K ﹤0.01%
11,515
– –
FIO
1868
DELISTED
FUSION-IO INC COM
FIO
$589K ﹤0.01%
52,100
-220,000
-81% -$2.04M
GEVA
1869
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$587K ﹤0.01%
5,600
+900
+19% +$76.6K
HLSS
1870
DELISTED
HOME LN SERVICING SOLUTIONS LTD(CAYMAN ISLANDS)
HLSS
$586K ﹤0.01%
25,800
+4,500
+21% +$99.4K
MDP
1871
DELISTED
Meredith Corporation
MDP
$585K ﹤0.01%
12,100
– –
DFT
1872
DELISTED
DuPont Fabros Technology Inc.
DFT
$582K ﹤0.01%
21,600
-59,300
-73% -$1.5M
ACIW icon
1873
ACI Worldwide
ACIW
$5.42B
$581K ﹤0.01%
31,200
– –
YELP icon
1874
Yelp
YELP
$1.32B
$575K ﹤0.01%
7,500
– –
IBOC icon
1875
International Bancshares
IBOC
$4.57B
$573K ﹤0.01%
21,214
+2,400
+13% +$58.6K
73 74
75
76 77

Similar funds

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates's Q2 2014 Portfolio in Review

As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
  • T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
  • T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
  • T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
  • T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
  • T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
  • T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.

Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.